Date: April 8, 2025 On April 8, 2025, the FDA granted regular approval to nivolumab (Opdivo) combined with ipilimumab (Yervoy)…
Browsing: Ipilimumab
Overview: The results from the Phase 3 CheckMate-8HW trial have just been released, demonstrating significant improvements in outcomes for patients…
Catherine Diefenbach, MD, a Hematologist and Medical Oncologist at NYU Langone Health, led a study titled “Results from an Intergroup…
In a conversation hosted by Allen Wilbanks, Solange Peters, MD, PhD, a full professor and chair of medical oncology specializing…
Dr. Kevin Harrington, Phd of the Royal Marsden Hospital, The Institute of Cancer Research, London, is the author of this…
Cholangiocarcinoma: Ipilimumab and Nivolumab Combo  MOASC Poster Session 2022 (Cholangiocarcinoma Ipilimumab Nivolumab) Hello, my name is Dalia Kaakour (clinical…